Taking these findings together with the increased immune cell infiltration in the pre-WGD region, we propose a model of tumour progression in patient #15 whereby increased genomic instability due to inactivation of TP53 could have resulted in rapid genomic changes, with such a region acting as a ‘clone factory’ where several daughter clones were produced. The gene discussed is TP53; the disease is neoplasm.